| Literature DB >> 26475950 |
Matthew Ferroni1, Aisha Khalali Taylor2.
Abstract
Asymptomatic bacteriuria (ASB) is a common finding and frequently detected in premenopausal nonpregnant women, institutionalized patients, patients with diabetes mellitus, and the ambulatory elderly population. Despite clear recommendations regarding diagnosis and management of ASB in these populations from the Infectious Diseases Society of America (IDSA), there remains an alarming rate of antimicrobial overuse. This article reviews definitions of ASB, epidemiology of ASB, literature surrounding ASB in diabetic patients, risk factors of ASB, microbiologic data regarding bacterial virulence, use of ASB strains for treatment of symptomatic urinary tract infection, and approaches to addressing translational barriers to implementing IDSA recommendations regarding diagnosis and management of ASB.Entities:
Keywords: Antimicrobial overtreatment; Asymptomatic bacteriuria; IDSA; Live biotherapeutics; Translational barriers; Urinary tract infection
Mesh:
Substances:
Year: 2015 PMID: 26475950 DOI: 10.1016/j.ucl.2015.07.003
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241